Skip to main content
BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———
Pricing
stocksAug 17, 2026, 6:22 AM

NRx Pharmaceuticals Posts Wider Q2 Loss, Misses Revenue Estimates

NRx Pharmaceuticals reported an adjusted Q2 loss of $0.18 per share, worse than the $0.09 loss expected, and revenue came in below estimates.

NRXP

NRx Pharmaceuticals, Inc. (NRXP) reported an adjusted second-quarter loss of $0.18 per share, compared with the Zacks Consensus Estimate of a $0.09 loss. The result was narrower than the adjusted loss of $0.98 per share recorded in the same period a year earlier.

The company also missed revenue estimates for the quarter. The reported earnings figures are adjusted for non-recurring items.

Source: FXStreet Forex News